Related Experiment Videos
Mannan binding lectin and the sudden infant death syndrome
D C Kilpatrick1, V S James, C C Blackwell
1Academic Unit, Blood Transfusion Service, Edinburgh, UK.
Forensic Science International
|January 1, 1999
Summary
Mannan-binding lectin (MBL) deficiency may not increase sudden infant death syndrome (SIDS) risk. However, higher MBL levels in SIDS infants suggest preceding bacterial infections may play a role in cot deaths.
Area of Science:
- Immunology
- Pediatrics
- Pathology
Background:
- Mannan-binding lectin (MBL) is crucial for innate immunity.
- Sudden infant death syndrome (SIDS) may be linked to bacterial infections.
- MBL deficiency could potentially increase SIDS susceptibility.
Purpose of the Study:
- To investigate the association between MBL concentrations and SIDS.
- To determine if MBL deficiency is a risk factor for SIDS.
Main Methods:
- MBL concentrations were measured in 46 SIDS infants and 26 control infants.
- Statistical analysis was performed to compare MBL levels between groups.
Main Results:
- The proportion of infants with low MBL levels was similar in both SIDS and control groups.
- The mean MBL concentration was significantly higher in the SIDS group (3 µg/ml) compared to the control group (2.2 µg/ml).
Conclusions:
- The findings suggest that elevated MBL levels in SIDS infants may indicate an acute phase response to bacterial infection.
- These results support the hypothesis that some SIDS cases might be preceded by bacterial infections, rather than MBL deficiency being a direct cause.